Aetna Inc. (AET) Financials Nov 17, 2014, 4:51 p.m.
Income
Aetna Inc. (AET) Financials Nov 17, 2014, 4:51 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Aetna Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 34.86B 34.28B 33.79B 36.61B 47.33B
Premiums Earned 30.14B 29.43B 28.97B 31.72B 41.84B
Total Investment Income 1.04B 1.06B 930.8M 918.3M 916.3M
Realized Gains (Losses) 149.5M 259.8M 178.1M 119.5M 27.8M
Other Operating Income 3.54B 3.53B 3.72B 3.85B 4.55B
Losses, Claims & Reserves 26.14B 24.73B 23.53B 26.55B 35.16B
Losses, Benefits & Adjustments 24.06B 22.72B 21.65B 23.6B 32.9B
2009 2010 2011 2012 2013 5-year trend
Selling, General & Admin. Expenses & Other 6.42B 6.61B 6.79B 6.97B 8.55B
Selling, General & Admin. Expenses 6.42B 6.61B 6.79B 6.85B 8.55B
Other Selling, General & Admin. Expense 5.17B 5.39B 5.68B 5.74B 7.2B
Underwriting & Commissions 1.25B 1.23B 1.1B 1.11B 1.35B
Other Operating Expense - - - 127M -
Operating Income Before Interest Expense 2.29B 2.93B 3.47B 3.08B 3.63B
Interest Expense, Net of Interest Capitalized 243.4M 254.6M 246.9M 268.8M 333.7M
Interest Expense (excl. Interest Capitalized) 243.4M 254.6M 246.9M 268.8M 333.7M
Interest Capitalized 0 0 0 0 0
Operating Income After Interest Expense 2.05B 2.68B 3.23B 2.81B 3.29B
Non-Operating Income (Expense) 0 0 0 0 0
Miscellaneous Non Operating Expense 0 0 0 0 0
Equity in Affiliates (Pretax) - - - - -
Unusual Expense 150M 32.3M 147.2M 268.9M 351.2M
Pretax Income 1.9B 2.64B 3.08B 2.55B 2.94B
Income Taxes 624.7M 877.4M 1.09B 887.5M 1.03B
Income Tax - Current - Domestic 718.6M 578.7M 1.04B 779.9M 957.6M
Income Tax - Current - Foreign - - - - -
Income Tax - Deferred - Domestic (93.9M) 298.7M 55.3M 107.6M 71M
Income Tax - Deferred - Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 1.28B 1.77B 1.99B 1.66B 1.91B
Minority Interest Expense 0 0 0 0 (1.7M)
Net Income 1.28B 1.77B 1.99B 1.66B 1.91B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 1.28B 1.77B 1.99B 1.66B 1.91B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 1.28B 1.77B 1.99B 1.66B 1.91B
EPS (Basic) 2.89 4.25 5.33 4.87 5.38
Basic Shares Outstanding 441.1M 415.7M 372.5M 340.1M 355.4M
EPS (Diluted) 2.84 4.18 5.22 4.81 5.33
Diluted Shares Outstanding 449.5M 422.9M 380.2M 345M 359.2M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...
Continue Reading
Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...
Continue Reading
Mobile money lives or dies in the irritating little moments: a transfer that hangs, a menu that makes people punch five buttons too many, a merchant payment that simply will not clear. Airtel Money is attacking that friction in Malawi and Tanzania with an enhanced platform from Comviva, and this is more consequential than the usual software-refresh chest thumping. In...
Continue Reading
A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...
Continue Reading
Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...
Continue Reading
Shelf labels are not exactly romance, yet Vusion has turned them into a serious growth machine. The 2030 plan is not really about hanging more electronic displays in aisles; it is about making those displays, sensors and store connections produce software and service revenue for years. That is the part of this story worth watching. The Hardware Base Is Becoming the Hook...
Continue Reading
Nothing says holiday restaurant marketing quite like putting spaghetti-shaped whipped topping on hot chocolate and trusting a 2003 movie to do the selling. Tim Hortons is rolling out an ELF-inspired menu at participating U.S. locations starting November 18, 2026, pairing the chain with Warner Bros. Consumer Products and mining Buddy the Elf's sugar-fueled world for a...
Continue Reading
Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...
Continue Reading
Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...
Continue Reading
A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...
Continue Reading
Top 5 Most Recently Viewed Articles
Dover Set to Release Q2 2025 Earnings Dover is gearing up to share its financial results for the second quarter of 2025, scheduled for release at approximately 6:00 a.m. Central time on the upcoming Thursday. This significant event marks a crucial moment for shareholders and analysts alike, as they anticipate insights into the company's performance and strategic moves....
Continue Reading
Investigation of ImmunityBio, Inc. In recent developments, Bragar Eagel & Squire, P.C., a well-respected law firm specializing in shareholder rights, has launched an investigation regarding ImmunityBio, Inc. (NASDAQ: IBRX). This probe is geared towards looking into potential legal claims on behalf of long-term shareholders, aiming to ensure their interests are safeguarded...
Continue Reading
Norges Bank's Recent Notification Regarding Stake in Syensqo Norges Bank has recently communicated a significant change regarding its participation in Syensqo. This notification, in line with Belgian transparency laws, reveals that Norges Bank has crossed the 3% voting rights threshold, which is vital for all stakeholders. Understanding the Changes in Voting Rights The...
Continue Reading
Key Developments in ZyVersa's Clinical Journey Important Highlights: Announcement of a Phase 2a proof-of-concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 focusing on patients with diabetic kidney disease planned for the first half of 2025. The regulatory framework for VAR 200’s primary indication, focal segmental glomerulosclerosis (FSGS), is set to...
Continue Reading
Overview of the Bunion Surgery Market The global Bunion Surgery Market is witnessing substantial growth, projected to increase from US$437.8 million in 2023 to an impressive US$606.1 million by 2029, achieving a CAGR of 5.7%. The surge in demand for surgical treatments primarily arises from the rising incidence of bunions, particularly among the aging population who are...
Continue Reading